Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations
MALVERN, PA — Endo International plc (NASDAQ: ENDP) announced that the U.S. Food and Drug Administration (the “FDA”) has requested a further stay of Endo’s ongoing litigation against the FDA through March 15, …
Read More